SBIR-STTR Award

Novel In Silico Models for ADMET Using Rapid Estimates of Quantum Chemical Descri
Award last edited on: 8/16/2019

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$624,998
Award Phase
2
Solicitation Topic Code
395
Principal Investigator
Robert Fraczkiewicz

Company Information

Simulations Plus Inc

42505 10th Street West
Lancaster, CA 93534
   (661) 723-7723
   info@simulations-plus.com
   www.simulations-plus.com
Location: Single
Congr. District: 23
County: Los Angeles

Phase I

Contract Number: 1R43CA130388-01
Start Date: 7/1/2007    Completed: 12/31/2007
Phase I year
2007
Phase I Amount
$99,998
New empirical descriptors to replace ab initio calculations will be generated to enable development of improved Ultra High Throughput (UHT, >200,000 compounds/hour) in silico models for Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) properties of molecules from their structures. Partial atomic charges, atomic and molecular reactivities, pKa, and related descriptors will be generated using computer models trained from a set of about 500 molecules for which most of the ab initio geometries have been optimized. This approach has been demonstrated by a preliminary model for partial atomic charges, which improved existing models for pKa and several ADMET properties. Phase I will complete the development of the charge model, implement atomic and molecular reactivity descriptors, and develop improved models for pKa as well as for a number of ADMET properties. Phase II will expand this work by developing additional models for ADMET properties using in-house and publicly available data sources. The models and new descriptors will be embodied in a commercially available software program already used by industry, government, and academic organizations to provide rapid and accurate estimation of ADMET properties, to help prioritize drug candidates for synthesis and screening. This project seeks to develop empirical quantum level descriptors for characterizing molecules, and to employ them in improved computer models to predict Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of molecules from their structures. These improved models will enable industry and government agencies to rapidly identify compounds with poor ADMET properties, thereby eliminating wasted experiments, and contributing to reduced risks to test subjects, reduced failed clinical trials, and safer, less costly therapies for patients.

Public Health Relevance Statement:


Project Terms:

Phase II

Contract Number: 2R44CA130388-02A1
Start Date: 7/1/2007    Completed: 3/31/2011
Phase II year
2009
(last award dollars: 2010)
Phase II Amount
$525,000

New empirical descriptors to replace ab initio calculations will be deployed for incorporation into new and improved Ultra High Throughput (UHT, >200,000 compounds/hour) in silico models for Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) properties of molecules, with only their 2D structures as input. In Phase I, we developed partial atomic charges including s and p components, atomic and molecular reactivities, and related descriptors from a dataset of almost 700 molecules. In Phase II we will augment the dataset with additional elements and complete the development of the charge model. Improved descriptor selection algorithms will be developed to capture the maximum information content of the new descriptors in model building. New and improved models for ADMET properties will be built using in-house and publicly available data sources. The models and new descriptors will be embodied in our commercially available software already in use by organizations worldwide to provide rapid and accurate estimation of ADMET properties to help prioritizing drug candidates for synthesis and screening.

Public Health Relevance:
Quantum level chemical descriptors have been demonstrated to provide improved predictions of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties in our Phase I effort. While traditional methods for calculating these descriptors from 3-dimensional molecular structures perform at a rate of only about one molecule per day, our Phase I approach enables calculation of these descriptors at the rate of hundreds of thousands of molecules per hour. The refined quantum level descriptors and predictive models to be developed under this Phase II effort are expected to model important charge and reactivity effects that are crucial to predicting such properties as metabolism and toxicity, including carcinogenicity.

Public Health Relevance Statement:
Project Narrative Quantum level chemical descriptors have been demonstrated to provide improved predictions of ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties in our Phase I effort. While traditional methods for calculating these descriptors from 3-dimensional molecular structures perform at a rate of only about one molecule per day, our Phase I approach enables calculation of these descriptors at the rate of hundreds of thousands of molecules per hour. The refined quantum level descriptors and predictive models to be developed under this Phase II effort are expected to model important charge and reactivity effects that are crucial to predicting such properties as metabolism and toxicity, including carcinogenicity.

Project Terms: